1Sewell WA, Jolles S. Immunomodulatory action of intravenous immunoglobulin. Immunology, 2002, 107:387-393.
2Gottstein R, Cooke RW. Systematic review of intravenous immunoglobulin in haemolybic disease of the newborn. Arch Dis Child Fetal Neonatal Ed, 2003, 88 :F6-10.
3D' Arena G, Musto P, Cascavilla N, et al. Flow cytometric characterization of human umbilical cord blood lymphocytes :immunophenotypic features. Haematological, 1998, 83:197-203.
4Amran D, Rena H, Lack G, et al. Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin. Clin Immunol Immunopathol, 1994, 73:180-186.
5Clement LT, Vink PE, Bradley GE. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4^+ ceils in the human neonate. J Immunol, 1990, 145:102-108.
6Klaesson S, Tammik L, Markling L, et al. Inhibition of immunoglobulin production in vitro by IgG and F( ab')2 fragments,but not by the Fc portion. Scand J Immunol, 1996, 43:574-582.
7Michie CA, McLean A, Alcock C, et al. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature, 1992, 360:264-265.
8Bayry J, Lacroix-Desmazes S, Carbonneil C, et al. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood, 2003, 101:758-765.
9Montanaro A, Pirofsky B. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states.Am J Med, 1984, 76:67-72.
10JIANG N,ZHANG R L,CHEN H,et al.Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient (2 h) but not after permanent MCA occlusion in the rat brain[J].Neurosci Res Commun,1994,15:85.
